Daily nutritional drink could reduce cognitive decline in very early Alzheimer’s disease

The full results from the European LipiDiDiet clinical trial has been published online in The Lancet Neurology today. The trial tested whether a daily medical nutritional drink called Souvenaid had any effect on cognitive decline in people in the very early stages of Alzheimer’s disease. The clinical trial involved 311 people with mild cognitive impairment…

Read More
Back To Top